WuXi AppTec, Inc., a leading global pharmaceutical and biotechnology company, is headquartered in China (CN) and operates extensively across North America, Europe, and Asia. Founded in 2000, the company has established itself as a pivotal player in the life sciences industry, providing comprehensive services that span drug discovery, development, and manufacturing. WuXi AppTec's core offerings include laboratory services, clinical trial support, and commercial manufacturing, distinguished by their commitment to innovation and quality. The company has achieved significant milestones, including the expansion of its facilities and capabilities, positioning itself as a trusted partner for biopharmaceutical companies worldwide. With a strong market presence and a reputation for excellence, WuXi AppTec continues to drive advancements in healthcare and accelerate the development of new therapies.
How does WuXi AppTec, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
WuXi AppTec, Inc.'s score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
WuXi AppTec, Inc., headquartered in China (CN), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of WuXi AppTec Co., Ltd., which may influence its climate commitments and reporting practices. Despite the absence of direct emissions data, WuXi AppTec, Inc. is part of a broader corporate family that may have established climate initiatives. However, there are no documented reduction targets or climate pledges available from WuXi AppTec, Inc. or its parent company. This lack of specific commitments suggests that the company may still be in the process of developing its climate strategy. As a participant in the biopharmaceutical industry, WuXi AppTec, Inc. operates in a sector increasingly focused on sustainability and carbon reduction. The absence of reported emissions data and reduction targets highlights an opportunity for the company to enhance its environmental accountability and align with industry standards for climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 6,643,770 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 144,938,320 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
WuXi AppTec, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.